New cell therapy tested for patients out of treatment options
Disease control
Recruiting now
This is the first human study to test the safety and early effects of an experimental cell therapy called KSV01. It is for adults with a specific type of aggressive blood cancer (B-cell non-Hodgkin lymphoma) that has come back or hasn't responded to other treatments. The main goa…
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC